Hepatitis C other diagnostic studies
|
Hepatitis C |
|
Diagnosis |
|
Treatment |
|
Hepatitis C other diagnostic studies On the Web |
|
American Roentgen Ray Society Images of Hepatitis C other diagnostic studies |
|
Risk calculators and risk factors for Hepatitis C other diagnostic studies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Varun Kumar, M.B.B.S. [2]
Recommendations for Utility of the Liver Biopsy and Noninvasive Tests of Fibrosis: AASLD Practice Guidelines 2009[1]
| “ |
1. A liver biopsy should be considered in patients with chronic hepatitis C infection if the patient and health care provider wish information regarding fibrosis stage for prognostic purposes or to make a decision regarding treatment (Class IIa, Level B) 2. Currently available noninvasive tests may be useful in defining the presence or absence of advanced fibrosis in persons with chronic hepatitis C infection, but should not replace the liver biopsy in routine clinical practice (Class IIb, Level C). |
” |
References
- ↑ Swan T, Curry J (2009). "Comment on the updated AASLD practice guidelines for the diagnosis, management, and treatment of hepatitis C: treating active drug users". Hepatology (Baltimore, Md.). 50 (1): 323–4, author reply 324–5. doi:10.1002/hep.23077. PMID 19554546. Retrieved 2012-02-21. Unknown parameter
|month=ignored (help)